FDA issued a Warning Letter to SCA Pharmaceuticals on 6/25/2015 for a previous inspection.
483 SCA Pharmaceuticals Sep 2017

483 SCA Pharmaceuticals Sep 2017

Nimmy Mathews FDA, Claire Minden FDA$119.00 - Available Now

FDA investigators audited the SCA Pharmaceuticals - Little Rock, AR, United States facility and issued inspectional observations (via FDA 483) on 29 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Sep 2017
  • Location: Little Rock, United States
  • FEI: 3010683157
Add To Cart